Edition:
India

Obalon Therapeutics Inc (OBLN.OQ)

OBLN.OQ on NASDAQ Stock Exchange Global Market

2.07USD
15 Feb 2019
Change (% chg)

$0.04 (+1.97%)
Prev Close
$2.03
Open
$2.06
Day's High
$2.15
Day's Low
$2.06
Volume
8,825
Avg. Vol
42,807
52-wk High
$4.54
52-wk Low
$1.46

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 2.99 -0.347
Jun '18 2.73 -0.572
Mar '18 1.35 -0.714
FY 2017 Dec '17 3.69 -0.598
Sep '17 2.79 -0.548
Jun '17 1.96 -0.465
Mar '17 1.47 -0.468
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 6 2.59 3.17 1.70 --
Quarter Ending Jun-19 6 2.43 3.30 1.70 --
Year Ending Dec-19 6 11.47 14.40 8.40 52.05
Earnings (per share)
Quarter Ending Mar-19 6 -0.34 -0.28 -0.42 --
Quarter Ending Jun-19 6 -0.33 -0.28 -0.38 --
Year Ending Dec-19 6 -1.35 -1.14 -1.64 -33.59
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -15.99 -- --
EPS (TTM) % -25.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Obalon Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 57.01%
# of Holders: 36
Total Shares Held: 13,273,973
3 Mo. Net Change: -789,033
# New Positions: 5
# Closed Positions: 8
# Increased Positions: 10
# Reduced Positions: 17
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.